139 related articles for article (PubMed ID: 33833995)
1. Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review.
Maelle R; Jean-Philippe R; Jochen W; Geraldine P; Fabrice C; Christian P; Mathilde G; Slimane D; Serge B; Naji S; Cecile V; Stanislas R; Thomas M; Sami F; Manuel T; Marc G; Gwenaelle G
Front Oncol; 2021; 11():644301. PubMed ID: 33833995
[No Abstract] [Full Text] [Related]
2. Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma.
Miller JA; Balagamwala EH; Angelov L; Suh JH; Rini B; Garcia JA; Ahluwalia M; Chao ST
J Neurosurg Spine; 2016 Dec; 25(6):766-774. PubMed ID: 27391397
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal metastases in renal cell carcinoma: A retrospective multicenter GETUG (Groupe d'Étude des Tumeurs Uro-Génitales) study.
Carneiro F; Vinceneux A; Larroquette M; Rony M; Carril L; Laguerre B; Blazevic I; Bartelemy P; Teyssonneau D; Goujon M; Linassier C; Thiery-Vuillemin A; Roubaud G; Mourey L; Albiges L; Gravis G; Gross-Goupil M; Cancel M
Eur J Cancer; 2024 Mar; 199():113534. PubMed ID: 38241819
[TBL] [Abstract][Full Text] [Related]
4. Treatments, Outcomes, and Validity of Prognostic Scores in Patients With Sarcomatoid Renal Cell Carcinoma: A 20-Year Single-Institution Experience.
Korenbaum C; Pierard L; Thiéry A; Story F; Lindner V; Lang H; Kurtz JE; Barthélémy P
Clin Genitourin Cancer; 2018 Jun; 16(3):e577-e586. PubMed ID: 29395949
[TBL] [Abstract][Full Text] [Related]
5. First-line tyrosine kinase inhibitors in metastatic renal cell carcinoma: A regional cancer center experience.
Rudresha AH; Chaudhuri T; Lakshmaiah KC; Babu GK; Lokanatha D; Jacob LA; Suresh Babu MC; Lokesh KN; Rajeev LK
Indian J Cancer; 2017; 54(4):626-630. PubMed ID: 30082547
[TBL] [Abstract][Full Text] [Related]
6. Overall survival after immunotherapy, tyrosine kinase inhibitors and surgery in treatment of metastatic renal cell cancer: outcome of 143 consecutive patients from a single centre.
De Lichtenberg TH; Hermann GG; Rørth M; Højer Larsen MJ; Mansourvar Z; Holm ML; Scheike T
Scand J Urol; 2014 Aug; 48(4):379-86. PubMed ID: 24521185
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era.
Kalra S; Verma J; Atkinson BJ; Matin SF; Wood CG; Karam JA; Lin SH; Satcher RL; Tamboli P; Sircar K; Rao P; Corn PG; Tannir NM; Jonasch E
Clin Genitourin Cancer; 2017 Jun; 15(3):363-370. PubMed ID: 28216278
[TBL] [Abstract][Full Text] [Related]
8. Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors.
Santoni M; Conti A; Partelli S; Porta C; Sternberg CN; Procopio G; Bracarda S; Basso U; De Giorgi U; Derosa L; Rizzo M; Ortega C; Massari F; Iacovelli R; Milella M; Di Lorenzo G; Buti S; Cerbone L; Burattini L; Montironi R; Santini D; Falconi M; Cascinu S
Ann Surg Oncol; 2015; 22(6):2094-100. PubMed ID: 25472645
[TBL] [Abstract][Full Text] [Related]
9. Evolving Patterns of Metastasis in Renal Cell Carcinoma: Do We Need to Perform Routine Bone Imaging?
Lin J; Zhang Y; Hou W; Qin Q; Galsky MD; Oh WK; Tsao CK
J Kidney Cancer VHL; 2021; 8(4):13-19. PubMed ID: 34722126
[TBL] [Abstract][Full Text] [Related]
10. Rare patients in routine care: Treatment and outcome in advanced papillary renal cell carcinoma in the prospective German clinical RCC-Registry.
Staehler M; Goebell PJ; Müller L; Emde TO; Wetzel N; Kruggel L; Jänicke M; Marschner N;
Int J Cancer; 2020 Mar; 146(5):1307-1315. PubMed ID: 31498894
[TBL] [Abstract][Full Text] [Related]
11. Radiation therapy following targeted therapy in oligometastatic renal cell carcinoma.
Gravis G; Faure M; Rybikowski S; Dermeche S; Tyran M; Calderon B; Thomassin J; Walz J; Salem N
Mol Clin Oncol; 2015 Nov; 3(6):1248-1250. PubMed ID: 26807228
[TBL] [Abstract][Full Text] [Related]
12. Radiation and Checkpoint Inhibitor Immunotherapy Lead to Long Term Disease Control in a Metastatic RCC patient With Brain Metastases.
Levitin M; Ofori J; Shin WJ; Huang J; Daly M; Cao D; Pachynski R
Front Oncol; 2020; 10():566070. PubMed ID: 33072598
[TBL] [Abstract][Full Text] [Related]
13. Impact of Systemic Therapy in Metastatic Renal-Cell Carcinoma Patients With Synchronous and Metachronous Brain Metastases.
Parmar A; Soliman H; Sahgal A; Bjarnason GA
Clin Genitourin Cancer; 2020 Jun; 18(3):e224-e232. PubMed ID: 32139300
[TBL] [Abstract][Full Text] [Related]
14. Changes in Treatment Reality and Survival of Patients With Advanced Clear Cell Renal Cell Carcinoma - Analyses From the German Clinical RCC-Registry.
Goebell PJ; Staehler M; Müller L; Nusch A; Scheffler M; Sauer A; von Verschuer U; Tech S; Kruggel L; Jänicke M; Marschner N;
Clin Genitourin Cancer; 2018 Dec; 16(6):e1101-e1115. PubMed ID: 30061035
[TBL] [Abstract][Full Text] [Related]
15. Can tyrosine kinase inhibitors be discontinued in patients with metastatic renal cell carcinoma and a complete response to treatment? A multicentre, retrospective analysis.
Johannsen M; Flörcken A; Bex A; Roigas J; Cosentino M; Ficarra V; Kloeters C; Rief M; Rogalla P; Miller K; Grünwald V
Eur Urol; 2009 Jun; 55(6):1430-8. PubMed ID: 18950936
[TBL] [Abstract][Full Text] [Related]
16. The development of brain metastases in patients with different therapeutic strategies for metastatic renal cell cancer.
Derks SHAE; van der Meer EL; Joosse A; de Jonge MJA; Slagter C; Schouten JW; Hoop EO; Smits M; van den Bent MJ; Jongen JLM; van der Veldt AAM
Int J Cancer; 2024 May; ():. PubMed ID: 38703351
[TBL] [Abstract][Full Text] [Related]
17. Impact of Tyrosine Kinase Inhibitors (TKIs) Combined With Radiation Therapy for the Management of Brain Metastases From Renal Cell Carcinoma.
Khan M; Zhao Z; Arooj S; Liao G
Front Oncol; 2020; 10():1246. PubMed ID: 32793497
[No Abstract] [Full Text] [Related]
18. Sequencing and Combination of Systemic Therapy in Metastatic Renal Cell Carcinoma.
de Velasco G; Bex A; Albiges L; Powles T; Rini BI; Motzer RJ; Heng DYC; Escudier B
Eur Urol Oncol; 2019 Sep; 2(5):505-514. PubMed ID: 31377308
[TBL] [Abstract][Full Text] [Related]
19. Does Bone-targeted Therapy Benefit Patients with Metastatic Renal Cell Carcinoma?
Wong ECL; Kapoor A
Transl Oncol; 2020 Feb; 13(2):241-244. PubMed ID: 31869748
[TBL] [Abstract][Full Text] [Related]
20. [Gastric or duodenal metastases from clear cell renal cell carcinoma. Report of two cases and review of the literature].
Haffner J; Morel JF; Maunoury V; Caty A; Biserte J; Villers A
Prog Urol; 2007 Nov; 17(7):1305-9. PubMed ID: 18271411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
